Advertisement

Topics

BioVectra Company Profile

05:13 EDT 26th September 2017 | BioPortfolio

We are an Eastern Canadian chemical manufacturer with over 35 years of experience serving a global customer base. BioVectra provides small to large scale custom manufacturing of active pharmaceutical ingredients and advanced intermediates along with a complement of core products targeted toward bioprocessing.
We currently operate out of three FDA-inspected facilities (June 2005) which are equipped to provide a range of contract services for our clients (highlighted below). BioVectra dcl's staff is knowledgeable in the requirements for commercialization of API's and we currently have three DMF's registered with the FDA.

Location

160 Christian Street
Oxford
Connecticut
06478
United States of America

Contact

Phone: 203-881-2020
Fax: 203-888-1143
Email: info@biovectra.com


News Articles [5 Associated News Articles listed on BioPortfolio]

BioVectra opening new site in Nova Scotia

BioVectra Inc., a contract manufacturer for pharmaceutical and biotech companies, is investing $30 million in the construction of a new microbial fermentation facility in Windsor, Nova Scotia in order...

BioVectra Inc. to Open New Microbial Fermentation and Complex Chemistry Site in December 2017

$30 million investment increases BioVectra’s total manufacturing capacity by 40% BioVectra Inc., a Contract Development and Manufacturing Organization (CDMO) providin...

Questcor Pharmaceuticals to Acquire BioVectra Inc.

ANAHEIM, Calif., Jan. 2, 2013 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) today announced that it has signed a definitive agreement to acquire all issued and outstanding shares ...

BioVectra Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 25072017] Prices from USD $250

SummaryBioVectra Inc BioVectra, a subsidiary of Mallinckrodt Plc is a manufacturer and marketer of pharmaceutical ingredients. The company's products include reducing reagents, bioprocessing reagents,...

Global DLDithiothreitol DTT Market Research 2011 2022 [Report Updated: 18042017] Prices from USD $1200

SummaryThe Global DLDithiothreitol DTT market is estimated to reach 2 MT in 2017. The objective of report is to define, segment, and project the market on the basis of type, application, and region, a...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [3 Associated Companies listed on BioPortfolio]

BioVectra Inc.

BioVectra Inc. is a privately-held, innovative cGMP drug development partner, custom manufacturer of API’s and bioprocess reagent supplier with 40 years experience serving th...

BioVectra

We are an Eastern Canadian chemical manufacturer with over 35 years of experience serving a global customer base. BioVectra provides small to large scale custom manufacturing of active pharmaceutical ...

BioVectra dcl

Protein engineering.

More Information about "BioVectra" on BioPortfolio

We have published hundreds of BioVectra news stories on BioPortfolio along with dozens of BioVectra Clinical Trials and PubMed Articles about BioVectra for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of BioVectra Companies in our database. You can also find out about relevant BioVectra Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record